These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 24765829
41. Application of distortion product otoacoustic emissions to inflation of the eustachian tube in low frequency tinnitus with normal hearing. Wang H, Song N, Li X, Lv H. Auris Nasus Larynx; 2013 Jun; 40(3):273-6. PubMed ID: 23103152 [Abstract] [Full Text] [Related]
42. Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma. Bhagat SP, Bass JK, White ST, Qaddoumi I, Wilson MW, Wu J, Rodriguez-Galindo C. Int J Pediatr Otorhinolaryngol; 2010 Oct; 74(10):1156-63. PubMed ID: 20667604 [Abstract] [Full Text] [Related]
43. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions. Fitzgerald TS, Prieve BA. J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804 [Abstract] [Full Text] [Related]
44. Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes. McMillan GP, Konrad-Martin D, Dille MF. Int J Audiol; 2012 Sep; 51(9):689-96. PubMed ID: 22676700 [Abstract] [Full Text] [Related]
45. Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions. Al-Malky G, Suri R, Dawson SJ, Sirimanna T, Kemp D. Int J Audiol; 2011 Feb; 50(2):112-22. PubMed ID: 21265638 [Abstract] [Full Text] [Related]
47. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure. Johnson TA, Baranowski LG. Ear Hear; 2012 Sep; 33(2):239-49. PubMed ID: 21918451 [Abstract] [Full Text] [Related]
48. Effects of aspirin on distortion product fine structure: interpreted by the two-source model for distortion product otoacoustic emissions generation. Rao A, Long GR. J Acoust Soc Am; 2011 Feb; 129(2):792-800. PubMed ID: 21361438 [Abstract] [Full Text] [Related]
49. [Study of the correspondence between pure tone and distorsion product otoacoustic emissions audiometrics: basis for an objective cochlear audiometrics model]. Jürgens A, Buisan A, Canela M, Abelló P. Acta Otorrinolaringol Esp; 1999 May; 50(4):253-9. PubMed ID: 10431072 [Abstract] [Full Text] [Related]
50. Evaluation of cochlear function in patients with normal hearing and tinnitus: a distortion product otoacoustic emission study. Satar B, Kapkin O, Ozkaptan Y. Kulak Burun Bogaz Ihtis Derg; 2003 May; 10(5):177-82. PubMed ID: 12970589 [Abstract] [Full Text] [Related]
51. Combined genetic polymorphisms of the GSTT1 and NRF2 genes increase susceptibility to cisplatin-induced ototoxicity: A preliminary study. Fujikawa T, Ito T, Okada R, Sawada M, Mohri K, Tateishi Y, Takahashi R, Asakage T, Tsutsumi T. Hear Res; 2024 Apr; 445():108995. PubMed ID: 38518393 [Abstract] [Full Text] [Related]
52. The relationship of high-frequency distortion product otoacoustic emission (DPOAE) values with hematological parameters in tinnitus patients. Gunes A, Karali E, Ural A, Ruzgar F, Bayatkara T. Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3013-3019. PubMed ID: 31372714 [Abstract] [Full Text] [Related]
53. Estimation of pure-tone thresholds in adults using extrapolated distortion product otoacoustic emission input/output-functions and auditory steady state responses. Hatzopoulos S, Ciorba A, Petruccelli J, Grasso D, Sliwa L, Kochanek K, Skarzynski H, Martini A. Int J Audiol; 2009 Nov; 48(9):625-31. PubMed ID: 19925336 [Abstract] [Full Text] [Related]
54. Interaural differences of distortion product otoacoustic emission amplitudes in patients with unilateral tinnitus. Park JP, Lim HW, Shim BS, Kim TS, Chung JW, Yoon TH, Park HJ. Otolaryngol Head Neck Surg; 2013 Mar; 148(3):456-9. PubMed ID: 23151834 [Abstract] [Full Text] [Related]
55. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions]. Dreher A, Suckfüll M, Schneeweiss S, Schorn K. Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504 [Abstract] [Full Text] [Related]
56. Otoacoustic emissions in young adults with a history of otitis media. Yilmaz S, Karasalihoglu AR, Tas A, Yagiz R, Tas M. J Laryngol Otol; 2006 Feb; 120(2):103-7. PubMed ID: 16359151 [Abstract] [Full Text] [Related]
57. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study. Bolay H, Bayazit YA, Gündüz B, Ugur AK, Akçali D, Altunyay S, Ilica S, Babacan A. Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433 [Abstract] [Full Text] [Related]
58. A review of the effectiveness of otoacoustic emissions for evaluating hearing status after newborn screening. Janssen T. Otol Neurotol; 2013 Aug; 34(6):1058-63. PubMed ID: 23628790 [Abstract] [Full Text] [Related]
59. Impaired cochlear function correlates with the presence of tinnitus and its estimated spectral profile. Zhou X, Henin S, Long GR, Parra LC. Hear Res; 2011 Jul; 277(1-2):107-16. PubMed ID: 21376109 [Abstract] [Full Text] [Related]
60. Evaluation of audiologic impairment in critically ill patients: results of a screening protocol. Hamill-Ruth RJ, Ruth RA. Crit Care Med; 2003 Sep; 31(9):2271-7. PubMed ID: 14501956 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]